Breast Cancer News and Research

Latest Breast Cancer News and Research

sanofi-aventis reports financial results for the third quarter of 2009

In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies.

30 Oct 2009

PIMCO Foundation awards grants to 30 US charities and community organizations

The PIMCO Foundation, the charitable arm of the Newport Beach-based money management firm PIMCO, today announced it has awarded $549,375 in 2009 grants to 30 US charities and community organizations.

30 Oct 2009

New social networking site for breast cancer survivors

Breast cancer activists, survivors and supporters now have their very own online Web community to share unique experiences and insights around breast cancer. Launching this week, the new social networking site “myKomen” centers on individual and shared experiences with a disease that will afflict 200,000 women and men this year alone.

30 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

Fourth annual 'Think Pink, Practice Pink' campaign to raise awareness and support a cure for breast cancer

Henry Schein, Inc., the largest distributor of healthcare products and services to office-based practitioners, once again partnered with the American Cancer Society for the fourth annual "Think Pink, Practice Pink" campaign to raise awareness and support a cure for breast cancer.

30 Oct 2009

University of Virginia Cancer Center commences patient treatment with the TomoDirect delivery mode

TomoTherapy Incorporated announced today that the first patients are now being treated with the TomoDirect™ radiation therapy delivery mode at the University of Virginia Cancer Center. The addition of the TomoDirect modality to the TomoTherapy® platform gives clinicians an efficient new option that expands their ability to fight cancer.

30 Oct 2009

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

Researchers at Thomas Jefferson University in Philadelphia, PA, supported in part by NuView Life Sciences, have published an article in the Journal of Nuclear Medicine reporting preclinical results of a novel PET biomarker designed to selectively detect malignant breast tumors.

30 Oct 2009

PEM scanners outperform MRI in detecting breast cancer

An NIH-sponsored, multi-year study of hundreds of women diagnosed with breast cancer found that Positron Emission Mammography (PEM) scanners significantly outperform MRI when differentiating between benign and cancerous lesions.

30 Oct 2009

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Celera Corporation, a health care company focused on genetics, and Medical Therapies Limited (ASX:MTY), a biotechnology company developing midkine-related diagnostic and therapeutic products, have entered into an exclusive license agreement for the use of MTY’s midkine patent portfolio for the development of novel lung cancer diagnostics.

30 Oct 2009

Novian Health and Rose Medical Center sign an agreement to provide Novilase laser treatment to treat breast lumps

Novian Health, manufacturer of Novilase™ Breast Therapy for benign breast tumors, announced an agreement with Rose Medical Center for Rose to provide the Novilase laser treatment to treat breast lumps.

29 Oct 2009

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

The following are highlights of new cancer research being presented at the American Society for Radiation Oncology's (ASTRO) 51st Annual Meeting on November 1-5, 2009, in Chicago.

29 Oct 2009

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

Despite a recent study finding that an increasing number of women who had cancer in one breast are opting to have the other breast removed, the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology(TM) for Breast Cancer discourages prophylactic mastectomy in women except for those considered high risk.

29 Oct 2009

Bankruptcy Rescue to offer free Chapter 7 bankruptcy filing services for breast cancer victims

Attorney Barton W. Morris, Jr., founder of Bankruptcy Rescue, announced today his team of bankruptcy lawyers will select one local family touched by breast cancer and facing financial crisis, to receive free Chapter 7 bankruptcy filing services from essays submitted online at www.mybankruptcyrescue.com/breastcancer before November 30, 2009.

29 Oct 2009

Routine use of HRT increases longevity in postmenopausal women

Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women.

29 Oct 2009

Avon Foundation for Women awards grant to improve reconstructive breast surgery

The Avon Foundation for Women has awarded the Clemson University Institute for Biological Interfaces of Engineering a $195,000 grant to support research to develop new ways to improve reconstructive breast surgery using engineered tissue that contains anti-cancer properties.

29 Oct 2009

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

The human body contains billions of microorganisms, and microbial cells found in the human gut are estimated to outnumber human cells by ten-to-one in healthy adults. However, little is known about the ways in which these minute life forms influence health and disease.

28 Oct 2009

Enrollment for Phase 2 clinical study of NKTR-102 completed ahead of schedule

Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.

28 Oct 2009

Critical illness insurance, an additional layer of financial protection

As breast cancer awareness month winds to a close and pink ribbons symbolizing the brave fight against this disease take their place on survivors' dressers, the fight continues. Putting the spotlight on this devastating disease has made people think about their own mortality and what would happen if they were diagnosed with a critical illness, says Frank N. Darras, America's top Long Term Disability Lawyer.

28 Oct 2009

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

Ghosts and goblins aren't the only spooky things lurking around this Halloween. A new report by the Campaign for Safe Cosmetics reveals that popular children's face paints contain lead, a potent neurotoxin, as well as nickel, cobalt and chromium, which can cause lifelong skin sensitization and contact dermatitis.

28 Oct 2009

NCI funds pilot study to measure human proteins

An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body.

28 Oct 2009

Breast Cancer News and Research

Latest Breast Cancer News and Research

sanofi-aventis reports financial results for the third quarter of 2009

PIMCO Foundation awards grants to 30 US charities and community organizations

New social networking site for breast cancer survivors

Eisai reports global Phase III study results of eribulin mesylate

Fourth annual 'Think Pink, Practice Pink' campaign to raise awareness and support a cure for breast cancer

University of Virginia Cancer Center commences patient treatment with the TomoDirect delivery mode

Researchers report preclinical results of a novel PET biomarker designed to detect malignant breast tumors

PEM scanners outperform MRI in detecting breast cancer

Celera to use Medical Therapies' midkine patent portfolio for development of novel lung cancer diagnostics

Novian Health and Rose Medical Center sign an agreement to provide Novilase laser treatment to treat breast lumps

Highlights of new cancer research to be presented at 51st ASTRO Annual Meeting

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

Bankruptcy Rescue to offer free Chapter 7 bankruptcy filing services for breast cancer victims

Routine use of HRT increases longevity in postmenopausal women

Avon Foundation for Women awards grant to improve reconstructive breast surgery

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

Enrollment for Phase 2 clinical study of NKTR-102 completed ahead of schedule

Critical illness insurance, an additional layer of financial protection

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

NCI funds pilot study to measure human proteins

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Breast Cancer News and Research

Latest Breast Cancer News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in